BioCube Beta vs. Market Capitalization
| BICB Stock | USD 0.0002 0.00 0.00% |
For BioCube profitability analysis, we use financial ratios and fundamental drivers that measure the ability of BioCube to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well BioCube utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between BioCube's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of BioCube over time as well as its relative position and ranking within its peers.
BioCube |
BioCube Market Capitalization vs. Beta Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining BioCube's current stock value. Our valuation model uses many indicators to compare BioCube value to that of its competitors to determine the firm's financial worth. BioCube is rated second in beta category among its peers. It is number one stock in market capitalization category among its peers creating about 3,605,548 of Market Capitalization per Beta. Comparative valuation analysis is a catch-all model that can be used if you cannot value BioCube by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for BioCube's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.BioCube Market Capitalization vs. Beta
Beta is one of the most important measures of equity market volatility. Beta can be thought of as asset elasticity or sensitivity to market. In other words, it is a number that shows the relationship of an equity instrument to the financial market in which this instrument is traded. For example, if Beta of equity is 2, it is expected to significantly outperform market when the market is going up and significantly underperform when the market is going down. Similarly, Beta of 1 indicates that an asset and market will generate similar returns over time.
BioCube |
| = | 0.87 |
In a nutshell, Beta is a measure of individual stock risk relative to the overall volatility of the stock market. and is calculated based on very sound finance theory - Capital Assets Pricing Model (CAPM).However, since Beta is calculated based on historical price movements it may not predict how a firm's stock is going to perform in the future.
Market Capitalization is the total market value of a company's equity. It is one of many ways to value a company and is calculated by multiplying the price of the stock by the number of shares issued. If a firm has one type of stock its market capitalization will be the current market share price multiplied by the number of shares. However, if a company has multiple types of equities then the market cap will be the total of the market caps of the different types of shares.
BioCube |
| = | 3.14 M |
In most publications or references market cap is broken down into the mega-cap, large-cap, mid-cap, small-cap, micro-cap, and nano-cap. Market Cap is a measurement of business as total market value of all of the outstanding shares at a given time, and can be used to compare different companies based on their size.
BioCube Market Capitalization vs Competition
BioCube is number one stock in market capitalization category among its peers. Market capitalization of Shell Companies industry is currently estimated at about 7.54 Million. BioCube totals roughly 3.14 Million in market capitalization claiming about 42% of equities listed under Shell Companies industry.
Beta Analysis
BioCube returns are very sensitive to returns on the market. As the market goes up or down, BioCube is expected to follow.
BioCube Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in BioCube, profitability is also one of the essential criteria for including it into their portfolios because, without profit, BioCube will eventually generate negative long term returns. The profitability progress is the general direction of BioCube's change in net profit over the period of time. It can combine multiple indicators of BioCube, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
BioCube, Inc., a development stage company, focuses on the development and marketing of lithium ion batteries in North America. The company was formerly known as Alliance Network Communications Holdings, Inc. and changed its name to BioCube, Inc. in December 2010. Biocube is traded on OTC Exchange in the United States.
BioCube Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on BioCube. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of BioCube position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the BioCube's important profitability drivers and their relationship over time.
Use BioCube in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if BioCube position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in BioCube will appreciate offsetting losses from the drop in the long position's value.BioCube Pair Trading
BioCube Pair Trading Analysis
The ability to find closely correlated positions to BioCube could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace BioCube when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back BioCube - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling BioCube to buy it.
The correlation of BioCube is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as BioCube moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if BioCube moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for BioCube can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your BioCube position
In addition to having BioCube in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Currency Funds Thematic Idea Now
Currency Funds
Funds or Etfs investing in a single currency or combination of currencies from different countries in order to replicate respective foreign exchange markets. The Currency Funds theme has 29 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Currency Funds Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in BioCube Pink Sheet
To fully project BioCube's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of BioCube at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include BioCube's income statement, its balance sheet, and the statement of cash flows.